# Prostatic Solitary Fibrous Tumor With Pulmonary Metastases: A Case Report

**Authors:** Yunus Kaygusuz, Fatih Kus, Feride Yilmaz, Mujdat Ayva, Olcay Kurtulan, Gunes Guner, Ahmet Gudeloglu, Mustafa Erman

PMC · DOI: 10.7759/cureus.94849 · Cureus · 2025-10-18

## TL;DR

A rare case of a prostate tumor that later spread to the lungs is reported, highlighting the need for long-term monitoring.

## Contribution

First reported case of a metastatic solitary fibrous tumor originating from the prostate.

## Key findings

- Prostatic SFT can metastasize to the lungs despite initially appearing benign.
- The patient remained in remission after surgical resection and chemotherapy.
- Long-term surveillance is essential for prostatic SFT due to potential late metastases.

## Abstract

Solitary fibrous tumors (SFT) are rare intermediate-grade mesenchymal neoplasms with unpredictable clinical courses, including the potential for late metastases. While most commonly arising in the pleura, extrapleural SFTs have been described. However, SFTs originating from the prostate are exceptionally rare, and their potential for metastatic progression remains largely unknown. A 59-year-old male presented with lower urinary tract symptoms and underwent Holmium laser enucleation of the prostate (HoLEP) after unsuccessful medical therapy. Histopathological examination revealed spindle-shaped neoplastic cells that were positive for cluster of differentiation 34 (CD34) and signal transducer and activator of transcription 6 (STAT6), confirming SFT. Radical prostatectomy was subsequently performed with negative surgical margins. Twenty-three months later, thoracic imaging detected two pulmonary nodules. Fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET) and percutaneous biopsy confirmed metastatic SFT. Both lung lesions were surgically resected, followed by adjuvant chemotherapy with ifosfamide and doxorubicin. The patient has remained in remission for 18 months. This case emphasizes that even histologically benign-appearing prostatic SFTs can demonstrate malignant potential. It also underscores the necessity of long-term surveillance and contributes to the literature by reporting the first known case of a metastatic SFT originating from the prostate gland.

## Linked entities

- **Proteins:** CD34 (CD34 molecule), STAT6 (signal transducer and activator of transcription 6)
- **Chemicals:** ifosfamide (PubChem CID 3690), doxorubicin (PubChem CID 31703)
- **Diseases:** solitary fibrous tumor (MONDO:0016238)

## Full-text entities

- **Genes:** STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, CD34 (CD34 molecule) [NCBI Gene 947]
- **Diseases:** Pulmonary Metastases (MESH:D009362), lung lesions (MESH:D008171), SFT (MESH:D054364), Fibrous Tumor (MESH:D009369)
- **Chemicals:** ifosfamide (MESH:D007069), doxorubicin (MESH:D004317)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12621071/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12621071/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12621071/full.md

---
Source: https://tomesphere.com/paper/PMC12621071